BAYLOR RESEARCH INSTITUTE

As filed

Subsection

03

NTEE code

H900

Classification

8000

Street

301 N WASHINGTON AVE

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Mission and programs · 2024

• See Schedule OEstablished in 1984, Baylor Scott & White Research Institute (BSWRI) is responsible for the oversight and management of all translational, observational, and clinical research conducted throughout the Baylor Scott & White Health (BSWH) system.BSWRI expanded its operations in 2013 as part of the merger between Dallas-based Baylor Health Care System and Temple-based Scott & White Healthcare, which created BSWH the largest nonprofit health system in Texas. Today, BSWH has over 1,300 patient access points including 53 hospitals, 600+ specialty care clinics, 250+ outpatient clinics, 150+ primary care clinics, 29 pharmacies, 30+ ambulatory surgery centers, 60+ urgent care clinics, and over 7,300 active physicians. The system also includes a state certified health maintenance organization, the Scott and White Health Plan and the Baylor Scott & White Quality Alliance accountable care organization both covering approximately 1,200,000 lives.BSWRI brings innovation to the forefront of medicine. From contributing to discoveries that help create new treatment options, to studying population health and other trends that improve quality of care, we pursue research focused on bringing patients greater value and addressing the health needs of the communities we serve. We are dedicated to advancing healthcare and ultimately, patient care, through the study and discovery of new preventive therapies and treatments for a broad spectrum of diseases and other chronic conditions. This means our efforts extend beyond microscopic studies; they bring innovation to the patient's bedside. We focus on understanding the base of a disease or condition, in order to then identify potential treatments or preventive therapies and enroll patients in research trials to further test and/or validate each theory. BSWRI is accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), which is a voluntary, peer-driven, and education-based model of accreditation.BSWRI is home to a rich network of over 600 team members operating within two administrative offices, four clinical trials offices, and directly within various BSWH centers, hospitals and clinics. Research staff include principal investigators, contracts and finance specialists, compliance and regulatory specialists, research coordinators, nurses, managers, data analysts and lab assistants, among others. The group oversees research activities supporting over 1,200studies in more than 50 specialty areas annually, including infectious disease, cardiology, gastroenterology, trauma, rehabilitation, neurology, oncology and radiation, orthopedics, pathology, radiology, transplant and surgery. Research conducted by and supported by our organization is regularly published in major scientific journals and reported at medical and scientific meetings. This work has also resulted in more than 1,600 issued and pending patents and trademark registrations spanning immunotherapy, genomics, biomarkers, metabolomics, metabolics, cardiovascular disease and medical devices. The following is a brief snapshot of activities led through BSWRI:Cardiovascular research: BSWRI holds a robust cardiovascular portfolio with study enrollment activities spanning multiple BSWH sites. Each year, we enroll and monitor hundreds of patients as part of major clinical trials examining therapeutic and surgical approaches and outcomes, new medications and new devices. Our cardiovascular research portfolio supports trials spanning: Atrial Fibrillation, Vascular/TAA conditions, Heart Failure Transplant, Heart Rhythm Disorders, Hypercholesterolemia, Aortic Valve Disorders, Cardiorenal Syndrome, Electrophysiology, Coronary Artery Disease, & Mitral Valve Disorders.Oncology research: The newest research hub within BSWRI is the Texas Cancer Interception Institute (TCII), created to attract and conduct innovative oncology clinical trials and research projects to help advance the science. Through advanced diagnostics, ground-breaking research, AI-enabled digital technology solutions, sophisticated meta-data analytics, and patient-centered support and command center, TCII is an innovation powerhouse transforming discoveries into life-changing treatments and leading early cancer detection efforts across Texas and beyond. TCII is uniquely empowered to lead 'implementation science' across BSWH via utilization of its state-of-the-science Oncology Command Center for development of various care coordination capabilities to offer novel early cancer detection pathways (such as blood-based Multi-Cancer Early Detection or MCED assays) and facilitate navigation of patients for timely, high-quality and reliable care across BSWH for cancer interception.The Center for Applied Health Research (CAHR) supports competitively funded investigator-initiated research to generate applied health knowledge across our health care system.It is a multidisciplinary, system-level research center within the Baylor Scott & White Research Institute (BSWRI) and serves as a collaborative for researchers, clinicians and community leaders who seek to improve health care delivery and health outcomes. The core value of CAHR is to support innovations that lead to improve outcomes and the value of care for our patients and community. We are located in Temple and Dallas, Texas.CAHR's research programs include: (1) Intervention development of community and family support programs for persons with dementia and their family caregivers (2) Implementation science of evidence-based programs leading to innovations in care delivery (3) Dissemination of evidence-based programs/practices for older adults from diverse settings (4) Healthcare delivery implementation programs to address critical illness outside of the ICU (5) Intervention development to support patients and families after critical illness and (6) Real-world clinical and economic evidence generation focused on drug therapy outcomes in ambulatory care.Trauma and behavioral health research: BSWRI supports trauma and behavioral health research across multiple sites and departments. Our research investigators take a collaborative and multidisciplinary approach to address physical, mental, and emotional trauma, which enhances ability to combine resources, inform best practices and further expand our ability to share our learnings out to others. One example of this work is found in the Warriors Research Institute (WRI). WRI's mission is to improve the quality of care available to military veterans and emergency responders via a program of scientific inquiry. Through BSWRI, WRI develops, evaluates, and disseminates information about treatment models for those suffering the sequelae of toxic or traumatic work events. In addition to providing and evaluating state-of-the-art experimental treatments, we train future generations of treatment providers in evolving evidence-based care. A second example is with the work done by the Trauma Research Center and Behavioral Health departments. These teams bring together the efforts of experienced researchers whose research focuses on trauma and related conditions resulting from a variety of etiologies including life events and the psychological conditions resulting from trauma. These researchers work closely with the trauma centers and rehabilitation teams at BSWH as well as external trauma centers across the country. They also study the psychological impacts of trauma-exposed occupational populations, such as healthcare personnel and active-duty service members.Transplant research: Our research efforts around transplantation take place at multiple sites including Baylor Scott & White All Saints Medical Center - Fort Worth, Baylor University Medical Center and Baylor Scott & White Medical Center - Temple. This research continues to hit major milestones and research firsts. BSWRI supports multiple trials examining transplant procedures and post-op care, as well as addressing transplant waitlists and organ shortages. Our efforts in the specialty of abdominal transplant, as well as heart and lung transplants, continue to support efforts to improve outcomes, inform access to organs, and educate medical staff on best practices. These include an investigator-initiated studies examining issues such as the global burden of alcohol-associated liver disease and the impact of new acuity circle policies for liver allocation. This work also extends to studies examining new artificial heart technologies for individuals needing a heart transplant.

  Expenses $75,562,410 · Revenue $34,302,370

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Officers and directors · 2024

As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.

Filings

• 2024

  Revenue

  $89,491,341

  Expenses

  $85,910,172

  Contributions

  $42,035,733

  Grants paid

  $0

• 2023

  Revenue

  $84,907,337

  Expenses

  $78,415,673

  Contributions

  $43,559,993

  Grants paid

  $0

• 2022

  Revenue

  $73,307,762

  Expenses

  $76,665,102

  Contributions

  $36,075,918

  Grants paid

  $0

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Other returns filed

• 2021 · 990

  Revenue

  $70,312,625

  Expenses

  $68,170,124

  Assets (EOY)

  $163,970,510

• 2020 · 990

  Revenue

  $77,117,798

  Expenses

  $65,145,979

  Assets (EOY)

  $167,191,620

• 2019 · 990

  Revenue

  $71,333,023

  Expenses

  $66,124,848

  Assets (EOY)

  $139,937,615

• 2018 · 990

  Revenue

  $69,331,263

  Expenses

  $69,230,447

  Assets (EOY)

  $165,250,659

• 2017 · 990

  Revenue

  $74,456,233

  Expenses

  $70,238,304

  Assets (EOY)

  $149,737,447

• 2016 · 990

  Revenue

  $67,527,910

  Expenses

  $67,109,598

  Assets (EOY)

  $136,825,951

• 2015 · 990

  Revenue

  $61,713,937

  Expenses

  $61,826,347

  Assets (EOY)

  $135,691,222

• 2014 · 990

  Revenue

  $61,768,964

  Expenses

  $63,008,893

  Assets (EOY)

  $138,238,739

• 2013 · 990

  Revenue

  $68,465,974

  Expenses

  $61,860,765

  Assets (EOY)

  $148,560,662

• 2012 · 990

  Revenue

  — not reported

  Expenses

  $62,159,368

  Assets (EOY)

  $151,818,242

Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.

Grants made

No itemized grants to organizations. Schedule I is filed only by organizations that granted more than $5,000 to a recipient, so most filers have none.

Grants received

• BAYLOR UNIVERSITY MEDICAL CENTER

  $13,840,680

  2023 · Medical Research

• BAYLOR HEALTH CARE SYSTEM FOUNDATION

  $10,380,334

  2024 · Medical Research, Equipment

• BAYLOR HEALTH CARE SYSTEM FOUNDATION

  $8,663,836

  2023 · Medical Research, Equipment

• BAYLOR HEALTH CARE SYSTEM FOUNDATION

  $7,833,045

  2022 · Medical Research, Equipment

• BAYLOR UNIVERSITY MEDICAL CENTER

  $6,561,248

  2022 · Medical Research

• SCOTT & WHITE HEALTHCARE FOUNDATION

  $1,966,534

  2024 · Medical Research

• SCOTT & WHITE HEALTHCARE FOUNDATION

  $1,482,651

  2023 · Medical Research

• SCOTT & WHITE MEMORIAL HOSPITAL

  $1,467,000

  2023 · Medical Research

• SCOTT & WHITE HEALTHCARE FOUNDATION

  $1,161,687

  2022 · Medical Research

• VANDERBILT UNIVERSITY MEDICAL CENTER

  $954,756

  2024 · Research

The 10 largest by cash amount. The API serves every itemized grant.

Related organizations

From Schedule R Part II, where a filer lists the tax-exempt organizations it is related to by control. It does not record shared board members or money.

Taxable family

From Schedule R Parts I, III and IV: entities that legally are the filer, and taxable partnerships, corporations and trusts it is related to. These record ownership and control, not shared board members or money.

Other IRS files